Concepedia

Ali Seddighzadeh

AS

15

Publications

1K

Citations

13

H-Index

2007

Active since

Affiliations

Biogen (United States)(Current)

Brigham and Women's Hospital

Harvard University

Beth Israel Deaconess Medical Center

Johns Hopkins University

Ali Seddighzadeh is an author at Biogen (United States) specializing in medicine, thrombosis, and pulmonary embolism.

Top concepts

Publications per year

2007–2021

15

Publications

15

Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

Peter A. Calabresi, Bernd C Kieseier, Douglas L. Arnold et al. · The Lancet Neurology · 2014 · 386 citations

, , +9

Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE

Bernd C. Kieseier, Douglas L. Arnold, Laura J. Balcer et al. · Multiple Sclerosis Journal · 2014 · 112 citations · Full text

Double Trouble for 2,609 Hospitalized Medical Patients Who Developed Deep Vein Thrombosis

Gregory Piazza, Ali Seddighzadeh, Samuel Z. Goldhaber · CHEST Journal · 2007 · 98 citations

, , +11

Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children

David J. Sas, Daniella Magen, Wesley Hayes et al. · Genetics in Medicine · 2021 · 72 citations · Full text

Venous thromboembolism in patients with active cancer

Ali Seddighzadeh, Ranjith Shetty, Samuel Z. Goldhaber · Thrombosis and Haemostasis · 2007 · 66 citations

, , +14

Rows per page

1–5 of 15